- pause slideshow
NHS preregistration training providers continue to out-do other providers in the registration assessment, with most achieving 100% pass rates for first-attempt candidates, according to figures from the General Pharmaceutical Council.
The Department of Health and Social Care will consult with the pharmaceutical industry over its plans to use new powers limiting the price of generics, the department’s permanent secretary has said.
A new cell-based seasonal influenza vaccine has been issued marketing approval by the European Commission and will be available for the 2019/2020 flu season.
With less than a month until the Falsified Medicines Directive is implemented on 9 February 2019, the Medicines and Healthcare products Regulatory Agency has confirmed that if there is a no-deal Brexit it will consider a UK-only version of the EU law.
The first monoclonal antibody therapy for migraine prevention has not been recommended by the National Institute for Health and Care Excellence on the grounds that it is not cost effective.
The General Pharmaceutical Council has opened its consultation on the initial education and training standards for pharmacists.
More information on how medicines, medical devices and clinical trials would be regulated following a no-deal Brexit has been issued by the Department of Health and Social Care.
An injectable drug for patients who struggle to control their asthma with inhalers has been approved by the National Institute for Health and Care Excellence.
Counterfeit tablets that contain the opioid fentanyl have been found in the UK for the first time.
The president of the British Pharmaceutical Students’ Association, Junel Ahmed, has stepped down from his role with immediate effect.
Three pharmacists and one former pharmacist have been recognised in the UK government’s 2019 New Year’s Honours list.
Pharmacists should manage medicines during transitions of care to improve medicines safety, NHS Improvement proposes
A nominated pharmacist should be designated to manage medicines during patient transitions between all settings, NHS Improvement has proposed as part of a consultation on medicines safety.
People who use emollient creams to treat dry and itchy skin conditions should be warned about the potential fire hazard, the Medicines and Healthcare products Regulatory Agency has said.
The Royal College of GPs has published interim guidance for GPs on the use of medical cannabis products.
Interventions to optimise antibiotic prescribing need to target general prescribing behaviour more widely, researchers have concluded.
The University of Sussex has confirmed that it is to close its Master of Pharmacy course.
On Wednesday 12 December 2018 at 20:00 (GMT), The Pharmaceutical Journal will be hosting an hour-long Twitter chat to discuss the issue of ethnicity and pay in UK pharmacy using #PJMindTheGap.
A programme designed to increase joint working between community pharmacists and GPs has deployed a pharmacist in all but two of a city’s GP surgeries.
Prescribers who will supervise pharmacist independent prescribers in training will not have to be mentored, contrary to earlier proposals, the General Pharmaceutical Committee has proposed
The interim protocol for the dispensing of adrenaline 150 microgram auto-injectors will cease to be in effect from 29 November 2018, the NHS has said.
Side effect of GilenyaSubscription
Side effects of ZytigaSubscription
NICE does not recommend ibrutinibSubscription
February 2016: SMC decisionsSubscription
New indication for InegySubscription
CPPE Prescriber's guideSubscription
NICE recommends ezetimibeSubscription
'Be Clear on Cancer' resourcesSubscription
Ativan is back in stockSubscription
Side effects of FruseneSubscription
Nplate indication extendedSubscription
Isoflurane not recommended for childrenSubscription
Glucose monitoring system recommended by NICESubscription
Etoposide SPC updateSubscription